Trump, lawmakers react after 'big, beautiful bill' clears Senate hurdle
Lawmakers from across the aisle are reacting to President Donald Trump's "big, beautiful bill" passing a key Senate vote on Saturday night.
Sen. Ron Johnson, R-Wis., who flipped his vote from a 'no' to 'yes' in dramatic fashion, said in a statement that the mammoth bill is a "necessary first step" to fiscal sustainability and cleaning up the mess left by the Biden administration.
"Biden and the Democrats left behind enormous messes that we are trying to clean up – an open border, wars, and massive deficits," Johnson said. "After working for weeks with President Trump and his highly capable economic team, I am convinced that he views this as a necessary first step and will support my efforts to help put America on a path to fiscal sustainability."
The 51-49 vote went along party lines, with only Sens. Thom Tillis, R-N.C., and Rand Paul, R-Ky., voting against unlocking a marathon 20-hour debate on the bill.
Senate Minority Leader Chuck Schumer, D-N.Y., was among the Democrats against what he called a "radical" bill.
"Senate Republicans are scrambling to pass a radical bill, released to the public in the dead of night, praying the American people don't realize what's in it," Schumer said in a statement. "If Senate Republicans won't tell the American people what's in this bill, then Democrats are going to force this chamber to read it from start to finish."
The bill will not immediately be debated thanks to Senate Democrats' plan to force the reading of the entire, 940-page legislative behemoth on the Senate floor.
Sen. Rick Scott, R-Fla., however, said he was "proud" to work with Trump on the bill and "put our nation on a path to balance the budget after years of Democrats' reckless spending."
Trump has said that he wants the bill, which must pass the Senate before being sent to the House for a vote, on his desk by July 4.
Trump called the Senate vote a "great victory" and directly praised Sens. Johnson, Scott, Mike Lee, R-Ariz., and Cynthia Lummis, R-Wyo., in a post on his Truth Social platform.
"They, along with all of the other Republican Patriots who voted for the Bill, are people who truly love our Country!" Trump wrote. "As President of the USA, I am proud of them all, and look forward to working with them to GROW OUR ECONOMY, REDUCE WASTEFUL SPENDING, SECURE OUR BORDER, FIGHT FOR OUR MILITARY/VETS, ENSURE THAT OUR MEDICAID SYSTEM HELPS THOSE WHO TRULY NEED IT, PROTECT OUR SECOND AMENDMENT, AND SO MUCH MORE. GOD BLESS AMERICA &, MAKE AMERICA GREAT AGAIN!!!"
In a second post, Trump wrote, "VERY PROUD OF THE REPUBLICAN PARTY TONIGHT. GOD BLESS YOU ALL! MAKE AMERICA GREAT AGAIN!!!"
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNN
7 minutes ago
- CNN
On GPS: Biden's NSA Jake Sullivan on Trump bombing Iran
From the Aspen Ideas Festival, Fareed asks Jake Sullivan what he makes of President Trump's decision to strike Iran's nuclear facilities, and whether the Biden administration overestimated Iran's strength as an adversary.
Yahoo
12 minutes ago
- Yahoo
Telix Pharmaceuticals (TLX) Announces That US FDA Approves Label Expansion for Illuccix
Telix Pharmaceuticals Limited (NASDAQ:TLX) is one of the 7 Best ASX Stocks to Buy Now. On June 23, the company announced that the US FDA approved a label expansion for Illuccix® (kit for the preparation of gallium Ga-68 gozetotide, for injection) to include patient selection for radioligand therapy (RLT) in the pre-taxane setting. A closeup of pills in a pharmacy, representing the high quality medications of the company. This update gets applied to Illuccix's third indication, for selecting patients who are indicated for PSMA-directed therapy as described in the Prescribing Information of the therapeutic products. The label expansion follows the approval by the US FDA of an expanded label for Pluvicto® (lutetium Lu177 vipivotide tetraxetan) for use in metastatic castration-resistant prostate cancer (mCRPC) patients after the treatment with androgen receptor pathway inhibitor (ARPI) therapy and before chemotherapy. Now that RLT is approved for earlier usage in the patient journey, the clinical utilization of Illuccix® is projected to increase by a minimum of 20,000 scans annually. In Q1 2025, Telix Pharmaceuticals Limited (NASDAQ:TLX)'s unaudited revenue came in at ~$186 million, representing an increase of 62% over the prior year corresponding quarter (Q1 2024: $115 million) and a QoQ rise of 31% (Q4 2024: $142 million). This includes $151 million from global sales of Illuccix® and $33 million from RLS Radiopharmacies (RLS) since the acquisition was completed on 27 January 2025. Telix Pharmaceuticals Limited (NASDAQ:TLX) stated that Illuccix continued to gain market share and maintain price stability amidst competition. Furthermore, Telix Pharmaceuticals Limited (NASDAQ:TLX) happens to be the only company with 2 FDA-approved PSMA-PET imaging agents – Illuccix and Gozellix. This allows it to broaden patient reach and maximize choice for the customers. Telix Pharmaceuticals Limited (NASDAQ:TLX)'s stock has a consensus one-year price target of $22.90. While we acknowledge the potential of TLX to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than TLX and that has 100x upside potential, check out our report about this cheapest AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
12 minutes ago
- Yahoo
7 College Majors That Cannot Afford a Comfortable Retirement
On average, going to college greatly improves your chances of financial success in terms of income, unemployment likelihood and reported financial well-being, as an analysis from the Association of Public & Land Grant Universities showed. However, your college major can make a difference when it comes to long-term financial security. I'm a Self-Made Millionaire: Check Out: In fact, 60% of the majors studied in a report by professors Frank Smith and Ajay K. Aggarwal would not lead to earning enough to build up a large enough nest egg to afford a comfortable retirement, even with no student loan debt. Once you factor in taking on more debt to go to college, the odds drop, especially for women and minorities. According to their findings, only certain STEM (Science, Technology, Engineering and Mathematics) and business-related majors are likely to earn enough over their lifetimes to afford a comfortable retirement. Even then, certain majors are not likely to lead to that outcome, particularly when factoring in debt. To get to a 50/50 chance of avoiding outliving your nest egg, you need a starting income of $48,500, according to the study. That's not to say that it's impossible to make up the gap later on, but below are seven majors and their typical starting pay, according to the research, which would not clear this bar: Major Starting pay Theatre $34,830 Hospitality management $38,250 Psych/sociology $38,610 Athletic training $39,860 English/writing $40,050 Political science $42,210 Food science $44,370 These are just a few of the many majors the report found would not earn enough. Even some STEM majors, like biology and chemistry, do not have high enough starting pay to lead to a comfortable retirement typically, they find. However, variations like chemical engineering do earn enough usually, with a starting pay of $65,520. While sometimes you need a particular major to get into a certain field, there are plenty of ways to adapt. Plus, just because some majors like biology might not lead to a comfortable retirement on average, that can certainly be used as a jumping-off point to get into medical school and then potentially secure a comfortable retirement as a doctor later on. Pay attention to what majors specific jobs or graduate schools may look for, but don't feel like you're always locked in. 'I still think that college grads can do okay with most majors, assuming they have an interest in taking a job outside their specific major field,' said Teresa Saputo-Crerend, co-founder of LaunchBreak, a networking platform for high-level women athletes. If you're willing to be flexible, leverage your contacts — including professors — and do the networking needed to land an internship, even if it's remote or during the school year, you can improve your chances of reaching your goals, she added. Plus, remember that getting your foot in the door is difficult, but it's important to keep doing the work. 'Getting a job these days is hard and can take up to a year. Patience, confidence and resilience are a necessity, as is finding some work to bridge the gap, preferably within the field one is looking for a job. For example, work at a retail clothing store if you are looking for a job in fashion; you never know who might be your customer,' said Saputo-Crerend. Learn More: If you've already graduated and are in a career that you don't think will lead to a secure retirement, or if you're deep into your studies, it's not necessarily too late to change direction. Pivoting is an option, said Saputo-Crerend. 'They can learn many, many different skills online,' she added. 'There are so many webinars and courses offered for free online. They can volunteer. They can try to do some job-shadowing. Pivoting requires patience as well.' Think about what skills you may have picked up along the way that can be used for this pivot too. College athletes, for example, typically develop 'time management, discipline, teamwork, etc. All of these soft skills can impress someone in any industry,' said Saputo-Crerend. 'It's the same for someone majoring in a field that won't be lucrative,' she noted. 'There is coursework in any major that teaches you skills. Psychology classes may require some coding, data analytics or behavioral research. This can all be applied to other industries.' More From GOBankingRates The New Retirement Problem Boomers Are Facing This article originally appeared on 7 College Majors That Cannot Afford a Comfortable Retirement
